Tar­get­ed ra­dio­ther­a­py biotech out of Lon­gi­tude Cap­i­tal rais­es a fresh $75M

Al­pha-9 Ther­a­nos­tics, a tar­get­ed ra­dio­ther­a­py biotech launched out of Lon­gi­tude Cap­i­tal last year, has raised $75 mil­lion in a Se­ries B round.

In­ter­est­ing­ly, how­ev­er, the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER